• Periprocedural MI Should Not Be an Endpoint

    Great controversy erupted after the report of the EXCEL trial of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with left main disease. I discussed it in this space in a piece I called, “What's Right about Left Main?” Much of that controversy was over the definition of periprocedural myocardial infarction (MI) used as a part of the composite endpoint of the trial.

    Author bio

    Cardiovascular Revascularization Medicine, 2021-01-01, Volume 22, Pages 124-125, Copyright © 2020 Elsevier Inc.



    Read the full article on Science Direct: Periprocedural MI Should Not Be an Endpoint

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details